Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in two upcoming investor conferences.
Dynavax Technologies Corporation , a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in the following ...
Analog Devices, Inc. today announced that the Company's Chief Executive Officer & Chair, Vincent Roche, will discuss business topics and trends at the Morgan Stanley Technology, Media & Telecom ...
AdventHealth's AI chief discusses the health system's careful implementation of the tech, focusing on patient care ...